Changhoon Ji
Executive Director AUTOTAC Bio
I am a molecular and cellular biologist by training, working at the Cellular Degradation Biology Center
in Seoul National University as a Research Associate Professor on the basic/translational science on autophagic Arg/N-degron pathway, as well as at AutotacBio, Inc. as the Chief Technology Officer on the drug development of heterobifunctional chimeric targeted protein degraders. My personal goal is to cover the entire width of the ‘basic science – translational science – clinical development’ spectrum for a comprehensive understanding and advancement of human health
Seminars
Wednesday 10th June 2026
Showcasing Safety, Pharmacokinetic & Efficacy Data in Phase 1b Trials in Humans & Phase 2 Trials in Canines for the Tau Aggregate Degrader ATB2005A
11:30 am
- Introducing the AUTOTAC platform and its mechanism-of-action
- Discussing ATB2005A as a first-in-class Tau aggregate degrader
- Revealing detailed clinical data on ATB2005A
Wednesday 10th June 2026
Showcasing Safety, Pharmacokinetic & Efficacy Data in Phase 1b Trials in Humans & Phase 2 Trials in Canines for the Tau Aggregate Degrader ATB2005A
12:00 pm
- Introducing the AUTOTAC platform and its mechanism-of-action
- Discussing ATB2005A as a first-in-class Tau aggregate degrader
- Revealing detailed clinical data on ATB2005A
